Windsor Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Windsor Capital Management's LLY Position: Q2 2026 in Review
Windsor Capital Management increased its Eli Lilly (LLY) stake by 0.39% in Q2 2026, buying an estimated $1.02K and bringing the position to 260 shares worth $312K. The position accounts for 0.08% of the portfolio, ranked #104.
Windsor Capital Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Windsor Capital Management held 260 shares of Eli Lilly worth $312K as of Q2 2026.
- Windsor Capital Management bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
- Eli Lilly made up 0.08% of Windsor Capital Management's portfolio in Q2 2026, its #104 holding.
- Windsor Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Windsor Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.